Treatment with GYY substantially mitigated the elevated expression of RXRα, RXRβ and RARγ1, suggesting an RXR and RAR regulatory role by GYY to mitigate PAI-1, MMP-9, MMP-13; thus, ECM turnover in diabetic kidney. This evidence concerns the gene MMP13 and diabetes mellitus.